Health
Clinical trial completion rates decline during COVID-19 pandemic – Science Daily
Social distancing and lockdowns may have affected clinical researchers’ ability to finish trials, researchers report. Study completion rates dropped worldwide between…
Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to finish trials. Study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and geographic location, between April and October 2020.Researchers previously reported that more than 80% of clinical trials suspended between March 1 and April 26, 2020, noted the…
-
Business16 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
General19 hours agoPope Leo XIV urges Hollywood actors to resist algorithms and save neighbourhood cinemas
-
Business18 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI
-
Business13 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025